Novel Clinical Utility of Retinal Imaging in Patients With Heart Failure
At a glance
Conditions
NCT05086978
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Cleveland Clinic
Cleveland, Ohiono site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- W. H. Wilson Tang, MD · PRINCIPAL_INVESTIGATOR · The Cleveland Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Retinal measurements and heart failure severity4 years
To generate the methodologies and establish workflow, and to generate preliminary data to demonstrate the association of retinal measurements with heart failure disease severity.
- Retinal measurements and exercise capacity4 years
To generate the methodologies and establish workflow, and to generate preliminary data to demonstrate the association of retinal measurements with exercise capacity represented by 6 Minute Walk Test distance